The MyLab™ 9 eXP delivers unprecedented precision, power and capability to drive more confident healthcare decisions in an increasingly demanding value-performance environment.
About Esaote: With a consolidated turnover of EUR 270 million in 2016, the Esaote Group is a leader in the biomedical equipment sector, in particular the areas of ultrasound, dedicated MRI and software for managing the diagnostic process. The Group currently employs 1,200 people. With its own production and research units in Italy and the Netherlands, Esaote is recognized as one of the top 10 diagnostic imaging companies in the world.
Esaote will be exhibiting MyLab 9 eXP at AIUM 2018. For more information please visit our online resources at www.esaoteusa.com
Esaote@AIUM 2018: Esaote will be exhibiting at AIUM- American Institute of Ultrasound in Medicine 2018, March 24th – March 28th, 2018.
LOCATION:
New York Hilton Midtown, New York, NY – AIUM 2018 – Booth #1407
* Technology and features are system/configuration dependent. Specifications are subject to change without notice. Information might refer to products or modalities not yet approved in all countries. For further details, please contact your Esaote sales representative.
SOURCE Esaote North America
Back to HCB News
